Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J9324 · per 10 MG

Inj, pemrydi rtu, 10 mg

Products billed under this code include Pemrydi rtu.

Payment limit per 10 MG, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9324

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Pemrydi rtu Amneal Pharmaceuticals, LLC 70121-2453-01 10 $635.80
Pemrydi rtu Amneal Pharmaceuticals, LLC 70121-2461-01 50 $3,179.00

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $63.58 −$4.355 10 MG Inj, pemrydi rtu, 10 mg v1, posted September 17, 2026
3Q26 $67.935 −$2.541 10 MG Inj, pemrydi rtu, 10 mg v1, posted September 15, 2026
2Q26 $70.476 −$2.842 10 MG Inj, pemrydi rtu, 10 mg v1, posted September 15, 2026
1Q26 $73.318 −$2.49 10 MG Inj, pemrydi rtu, 10 mg v1, posted September 15, 2026
4Q25 $75.808 −$4.292 10 MG Inj, pemrydi rtu, 10 mg v1, posted September 8, 2026
3Q25 $80.10 −$0.957 10 MG Inj, pemrydi rtu, 10 mg v1, posted March 10, 2026
2Q25 $81.057 −$1.078 10 MG Inj, pemrydi rtu, 10 mg v1, posted March 10, 2026
1Q25 $82.135 – 10 MG Inj, pemrydi rtu, 10 mg v1, posted December 19, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files